Anti-CD20/CD3 T cell–dependent bispecific antibody for the treatment of B cell malignancies

• DOI: 10.1126/scitranslmed.aaa4802
• Publication Date: 2015-05-13T18:51:30Z
• Authors: Liping L. Sun; Diego Ellerman; Mary Mathieu; Maria Hristopoulos; Xiaocheng Chen; Yijin Li; Xiaojie Yan; Robyn Clark; Arthur Reyes; Eric Stefanich; Elaine Mai; Judy Young; Clarissa Johnson; Mahrukh Huseni; Xinhua Wang; Yvonne Chen; Peiyin Wang; Hong Wang; Noel Dybdal; Yu-Waye Chu; Nicholas Chiorazzi; Justin M. Scheer; Teemu Junttila; Klara Totpal; Mark S. Dennis; Allen J. Ebens
• Keywords: Bispecific antibody

Anti-CD20/CD3 T cell–dependent bispecific antibodies may be useful for the treatment of B cell malignancies.